- Home
- Products
- Customized ADCs
- S. epidermidis LTA
- Anti-S. epidermidis LTA (Pagibaximab)-MC-MMAF ADC
Anti-S. epidermidis LTA (Pagibaximab)-MC-MMAF ADC (CAT#: ADC-W-2260)
This ADC product is comprised of an anti-S. epidermidis LTA monoclonal antibody conjugated via a MC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
- ADC Target
- ADC Antibody
- ADC Linker
- ADC payload drug
- Name
- S. epidermidis LTA
- Alternative Names
- S. epidermidis LTA
- Overview
- Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
- Overview
- Chimeric Anti-S. epidermidis LTA IgG1-kappa antibody, Pagibaximab
- Generic name
- Pagibaximab
- Host animal
- Mouse
- Name
- MC (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
- Name
- MMAF
- Description
- Derived from Auristatin,are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-ITGA4+ITGB7 (Vedolizumab)-MC-MMAF ADC (CAT#: ADC-W-2494)
- Anti-EGFR (Imgatuzumab)-SPDB-DM4 ADC (CAT#: ADC-W-1065)
- Anti-IL4 (Pascolizumab)-MC-MMAF ADC (CAT#: ADC-W-1378)
- Anti-MUC1 (Cantuzumab )-MC-MMAF ADC (CAT#: ADC-W-1612)
- Anti-CD28 (lulizumab pegol)-MC-MMAF ADC (CAT#: ADC-W-2332)
- Anti-APP (Bapineuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-707)
- Anti-FCER2 (Gomiliximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1147)
- Anti-ERBB2-PEG-cycloalkyne-MMAF ADC (CAT#: ADC-W-175)
- Anti-FAP (Sibrotuzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-1133)
- Anti-FXYD5-PEG-cardiac glycoside ADC (CAT#: ADC-W-079)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-2260. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
Same Payload
| CAT# | Product Name | Linker | Payload |
| ADC-W-2263 | Anti-S. epidermidis LTA (Pagibaximab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-2262 | Anti-S. epidermidis LTA (Pagibaximab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-2259 | Anti-S. epidermidis LTA (Pagibaximab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-2261 | Anti-S. epidermidis LTA (Pagibaximab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-2258 | Anti-S. epidermidis LTA (Pagibaximab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| CAT# | Product Name | Linker | Payload |
| ADC-W-491 | Anti-TNFRSF17-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-537 | Anti-TPBG-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-114 | Anti-CD33-Mc-MMAF ADC-3 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-478 | Anti-ENPP3-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-2606 | Anti-ITGB3 (Tadocizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| CAT# | Product Name | Linker | Payload |
| ADC-AA-063 | Anti-HIgG(Fab)-N-MMAF ADC | Noncleavable linkers | MMAF |
| ADC-W-2544 | Anti-CD44 (Bivatuzumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2556 | Anti-CD79B (Polatuzumab )-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2622 | Anti-NCAM1 (Lorvotuzumab )-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-2612 | Anti-MS4A1 (Rituximab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
